CIK 0001401040 · Non-accelerated filer<br>Smaller reporting company
DiaMedica Therapeutics Inc.
Sign in to watch- Ticker
- DMAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Canada (Federal Level)
- Entity type
- operating
- Phone
- (763) 496-5454
- Business address
- 301 CARLSON PARKWAY, SUITE 210, MINNEAPOLIS, MN, 55305
- Former names
- DiaMedica Inc.
- 4 Grant or award Director acquired 7,745 shares (grant or award)
- 4 Grant or award Director acquired 9,719 shares (grant or award)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market buy Director bought 10,000 shares at an average $5.37 ($53,697)
- 4 Open-market buy Director bought 15,000 shares at $4.26 ($63,912)
- 4 Open-market buy CFO and Secretary bought 2,000 shares at $4.19 ($8,387)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement · Regulation FD disclosure
- 424B5 Offering Prospectus
- 8-K Event Results of operations · Other events
- 424B5 Offering Prospectus
- 8-K Event Shareholder vote results · Other events
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 7,784 shares (grant or award)
Page 16 of 22 · 429 filings